Related Experiment Video
Updated: Jul 12, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Challenges in Identifying Biomarkers of Frailty Syndrome: A Systematic Review
Indira Omarova1, Ainur Yeshmanova1, Gulzhan Gabdulina1
1Department of General Medical Practice, Kazakh National Medical University Named After S.D. Asfendiyarov, 94 Tole bi, Almaty 050069, Kazakhstan.
Abstract:
Background and Objectives: The aim of this study is to categorize and combine (according to the source of biomaterial) biomarkers of frailty syndrome and identify challenges in research on these biomarkers by reviewing the current literature from the past five years. Methods: We systematically searching five electronic databases-PubMed, Scopus, Web of Science, CINAHL, and the Cochrane Library-for citations from 1 January 2019 to 1 July 2024. We conducted a qualitative data synthesis and categorized the limitations by topics and subtopics. PROSPERO-CRD: 42024491369. Results: A total of 61 papers met the criteria for inclusion in this study. These studies included a total of 56,758 participants, and 1479 unique biomarkers. We categorized biomarkers such as blood, genetic, urinary, and salivary biomarkers. Our analysis identified three major categories of challenges: challenges related to study design, unclear pathophysiological mechanisms, and biomarker-specific challenges. Conclusions: This review underscores the extensive research into biomarkers associated with frailty syndrome, such as blood, genetic, urinary, and salivary biomarkers. However, significant challenges persist, including methodological inconsistencies, biomarker measurement variability, and a limited understanding of underlying mechanisms.
Related Concept Videos
Data Validation
Key parameters for method validation include:
Toxicity Testing in Animals
Methods of Classification and Identification
Rapid Identification of Pathogens

